Polypharmacy

George is seventy-eight. Every morning at six-thirty, he opens a plastic pill organizer the size of a paperback novel and begins. A statin for cholesterol. Two blood pressure medications. Metformin for diabetes. A thyroid replacement pill. A proton pump inhibitor for acid reflux. Gabapentin for the neuropathy in his feet. A low-dose aspirin his previous cardiologist started eight years ago. An antidepressant his primary care doctor prescribed after his wife died. A sleep aid he requested when the antidepressant kept him awake. A vitamin D supplement. A fish oil capsule his daughter bought him. And two medications added during his hospitalization for pneumonia last winter that no one discussed stopping when he was discharged.

Fourteen pills. Three prescribers. None of them has seen the complete list.

George’s situation is not unusual. Over 90 percent of adults over sixty-five take at least one prescription medication. More than a third take five or more. Among those over eighty, close to half are on five or more drugs simultaneously. The proportion of older Americans on ten or more medications has been climbing for two decades. Each prescription, taken individually, was probably reasonable when it was written. Taken together, they constitute a system that no single clinician designed, no single clinician monitors, and no single clinician fully understands.

How the Pile Grows

The medical term is polypharmacy, typically defined as the concurrent use of five or more medications. The term itself is neutral; some people genuinely need five drugs. The problem is not the number alone. It is the absence of anyone looking at the whole.

Medications accumulate through a process clinicians call the prescribing cascade. A blood pressure medication causes ankle swelling. A diuretic is added for the swelling. The diuretic depletes potassium. A potassium supplement is prescribed. The supplement irritates the stomach. A proton pump inhibitor is added for the stomach. Each step makes clinical sense in isolation. In sequence, it is a chain reaction that no one set out to create.

Hospitalization accelerates the process. When a person is admitted, new medications are often started: antibiotics, anticoagulants, pain medications, acid suppressants to prevent stress ulcers. At discharge, these medications are frequently continued without a clear plan for stopping them. The primary care physician receives a discharge summary that lists the new drugs but rarely explains the intended duration. Six months later, the patient is still taking a proton pump inhibitor that was meant to last two weeks.

Specialist fragmentation compounds the problem. A cardiologist manages heart medications. An endocrinologist handles diabetes. A neurologist prescribes for neuropathy. A psychiatrist or primary care doctor manages the antidepressant. Each operates within their domain. The interaction effects between domains go unreviewed unless someone, usually the patient or a family member, insists on a comprehensive look.

What the Pile Does to an Aging Body

The body at seventy-eight does not process medications the way it did at fifty. Kidney function declines, slowing the clearance of drugs that are eliminated through the kidneys. Liver metabolism changes. Body composition shifts: less water, less muscle, more fat, altering how drugs distribute and how long they remain active. A dose that was appropriate at sixty may be excessive at seventy-five, even if nobody has adjusted it.

The consequences are specific and well-documented. Sedating medications (benzodiazepines, certain antihistamines, sleep aids, opioids) increase fall risk, and as installment 3E described, falls kill nearly 39,000 older Americans each year. Anticholinergic medications, a category that includes many common drugs such as diphenhydramine (Benadryl), certain bladder medications, and older antidepressants, carry a cumulative burden: the more anticholinergic drugs a person takes, the higher their risk of confusion, constipation, urinary retention, and cognitive decline. The 2023 AGS Beers Criteria, the standard reference for potentially inappropriate medications in older adults, expanded its warnings about this cumulative anticholinergic burden precisely because the risk compounds across prescriptions.

Proton pump inhibitors, among the most commonly prescribed drugs in older adults, reduce absorption of calcium, magnesium, and vitamin B12 when used long-term, contributing to the bone loss described in installment 3F and potentially worsening the neuropathy they were never meant to treat. Metformin depletes B12 over time. The interactions multiply.

Perhaps the most alarming finding in the polypharmacy literature is that each additional medication increases the risk of an adverse drug event not in a straight line but on a curve. The jump from four medications to seven carries more additional risk than the jump from one to four. By the time a person reaches ten concurrent prescriptions, the probability that at least two of those drugs are interacting in a clinically meaningful way approaches near-certainty.

The Deprescribing Conversation

Deprescribing is the supervised, deliberate process of reducing or stopping medications when their risks outweigh their benefits. It is not the same as abruptly stopping a drug, which can be dangerous. It is not anti-medication. It is pro-appropriateness: the recognition that a prescription that helped at sixty-five may be causing harm at seventy-eight.

The evidence supports it. Reviews in the Annual Reviews of Medicine and other journals have confirmed that structured deprescribing is both feasible and safe in older adults. Multi-center trials published in early 2026 showed that systematic medication review in hospitalized elderly patients successfully reduced inappropriate prescriptions, though questions remain about whether the benefits persist after discharge without ongoing follow-up.

The barriers are formidable. Physicians trained in prescribing are not equally trained in stopping. The fifteen-minute office visit leaves no room for reviewing fourteen medications, their interactions, and their ongoing necessity. Patients themselves often resist, having been told for years that each pill is essential. The psychological equation is lopsided: starting a medication feels like doing something, while stopping one feels like giving up.

There is also a liability dimension that rarely gets discussed openly. A physician who prescribes a standard medication and the patient has an adverse event is practicing within the norm. A physician who stops a medication and the patient has a problem faces a different kind of scrutiny. The system incentivizes addition over subtraction.

Where Technology Enters

Artificial intelligence is beginning to offer tools for identifying dangerous medication combinations that overwhelm human pattern recognition. Clinical decision support systems can flag drug-drug interactions across a patient’s full medication list in seconds, something that would take a pharmacist considerable time to do manually. Machine learning models are being trained to predict which patients are at highest risk for adverse drug events based on their specific combination of medications, diagnoses, and physiological characteristics.

At Duke University, researchers are building models that recommend which central nervous system-active medication to deprescribe first based on individual clinical profiles. The work targets sedating polypharmacy (pain, sleep, and anxiety medications taken in combination), which has doubled in the past decade among older adults. The models use explainable AI techniques so that clinicians and patients can understand the reasoning behind the recommendation, not just the recommendation itself.

A 2025 review in Expert Review of Clinical Pharmacology, the first comprehensive assessment of AI’s role in deprescribing for older patients, found that AI tools can effectively identify potentially inappropriate medications and predict adverse events. But the same review noted that only five studies met inclusion criteria for rigorous evaluation. The field is promising. It is also very young. No algorithm currently available replaces the clinical judgment of a geriatrician or the knowledge a patient has about their own body. And no AI tool addresses the fundamental problem: someone has to act on the information. A flag in a computer system is useless if no clinician reads it.

At the Kitchen Table

If you are taking five or more medications, you need a comprehensive medication review. Not a glance at the list during a routine visit. A dedicated conversation, ideally with a geriatrician or a clinical pharmacist trained in medication reconciliation, where every drug is evaluated for ongoing necessity, appropriate dosing, and interaction risk.

Prepare for that conversation. Write down every medication you take, including over-the-counter drugs, supplements, and anything you buy without a prescription. For each one, note who prescribed it, when, and why. Bring the bottles if that is easier than the list. This is what clinicians call a “brown bag review,” and it remains the simplest and most effective tool for catching problems that have accumulated unnoticed.

Ask specific questions. What is this medication for? Is it still necessary? What would happen if we stopped it? Are any of these drugs interacting with each other? Has the dose been adjusted for my current age and kidney function? These are not confrontational questions. They are the questions good medicine depends on.

The 2023 Beers Criteria recommended against initiating aspirin for primary prevention in older adults, reversing decades of routine prescribing. If your aspirin was started years ago “just in case” and you have never had a heart attack or stroke, ask whether it should continue. Ask about the proton pump inhibitor you have been on since your fifties. Ask about the sleep aid that was supposed to be temporary.

Every installment in this series has touched on medications: the cardiovascular drugs in 3A, the diabetes medications in 3B, the pain prescriptions in 3C, the balance-disrupting drugs in 3E, the bisphosphonates in 3F. Polypharmacy is the thread that runs through all of them. It is also the one problem where the most powerful intervention is not a new drug, a new device, or a new algorithm. It is a conversation. The question is whether anyone has time to have it.